Establishment of a new parameter of glycemic variability assessed by continuous glucose monitoring in type 1 diabetes.
Not Applicable
Completed
- Conditions
- type 1 diabetes
- Registration Number
- JPRN-UMIN000018430
- Lead Sponsor
- Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
Severe chronic heart failure more than the 3 grade in the NYHA classification. Severely impaired hepatic or renal function. Severe infection, heavy use of alcohol, perioperative status, pregnant or breastfeeding women or other reasons leading to the physician in charge to judge that the patient was unsuitable for study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glycemic variability in type 1 diabetes as studied in JPRN-UMIN000018430?
How does the new glycemic variability parameter compare to standard-of-care metrics in T1D management?
What biomarkers correlate with glycemic instability in type 1 diabetes patients using CGM data?
Are there specific adverse events associated with continuous glucose monitoring in pediatric T1D populations?
What combination therapies have shown improved glycemic control in type 1 diabetes alongside CGM implementation?